Ken Ren Net Worth & Insider Trades
Ken Ren - CEO and Director, Casi Pharmaceuticals, Inc
What is Ken Ren's Net Worth?
The current estimated net worth of Casi Pharmaceuticals, Inc's CEO and Director, Ken Ren, is estimated to be about $4.62M . Ken Ren owns about 15,000 units of Casi Pharmaceuticals, Inc common stock. Recently at Casi Pharmaceuticals, Inc, Ken Ren has sold an estimated value of $0 worth.
What is Ken Ren's Past Insider Trading?
Ken Ren's largest purchase order was 15,000 units , worth over $10.89K on January 21, 2016. In total, Ken Ren has made about 1 transaction recently at Casi Pharmaceuticals, Inc. Ken Ren usually trades in January, with the busiest year in 2016.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ken Ren
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Ken Ren's' Mailing Address?
- Mailing address is 3rd Fl, Borough A, Block A No. 181 South Taibai Road Xi'An, Shaanxi Province F4 710065 China
Casi Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Wei-Wu He, Ph.D. | 2020 | $577,656 | - | - | - | - | $241,831 | $819,487 |
| Wei-Wu He, Ph.D. | 2019 | $423,848 | - | - | $8,600,000 | - | $241,555 | $9,265,103 |
| Wei (Larry) Zhang | 2020 | $437,094 | - | - | - | - | $278,675 | $715,769 |
| Wei (Larry) Zhang | 2019 | $339,207 | - | - | $450,000 | - | $166,889 | $985,186 |
| Alexander Zukiwski, MD | 2020 | $414,529 | - | - | - | - | $28,250 | $442,779 |
| Alexander Zukiwski, MD | 2019 | $407,600 | $100,000 | - | $426,000 | - | $27,750 | $961,350 |
| Weihao Xu | 2020 | $14,583 | - | - | $1,440,000 | - | - | $1,454,583 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/895051/000110465921063604/tm2114348d2_def14a.htm
What are Casi Pharmaceuticals, Inc's Past Insider Trades?
Casi Pharmaceuticals, Inc's most recent insider trade came on September 8, 2022 by James Huang who bought 55,573 units worth $229.66K . In the last 6 years, insiders at Casi Pharmaceuticals, Inc have sold an estimated value of $5.53M and bought an estimated value of $56.36M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Wei-Wu He, Chairman and CEO, James Huang, Director, and Cynthia W Hu, COO .
CASI Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||